Compare HELE & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HELE | KMDA |
|---|---|---|
| Founded | 1968 | 1990 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 390.4M | 458.6M |
| IPO Year | 1996 | 2013 |
| Metric | HELE | KMDA |
|---|---|---|
| Price | $16.94 | $9.12 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $22.00 | $13.00 |
| AVG Volume (30 Days) | ★ 540.3K | 67.7K |
| Earning Date | 04-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.18% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,478,845,000.00 | N/A |
| Revenue This Year | N/A | $14.79 |
| Revenue Next Year | $0.67 | $11.38 |
| P/E Ratio | ★ N/A | $24.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.22 | $5.54 |
| 52 Week High | $57.68 | $9.35 |
| Indicator | HELE | KMDA |
|---|---|---|
| Relative Strength Index (RSI) | 40.70 | 59.48 |
| Support Level | $16.55 | $6.69 |
| Resistance Level | $19.26 | $9.35 |
| Average True Range (ATR) | 0.86 | 0.25 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 20.70 | 76.84 |
Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.